cGMP modulates basal and activated microvessel permeability independently of [Ca2+](i)

P. He, M. Zeng, F. E. Curry

Research output: Contribution to journalArticle

Abstract

To investigate the mechanisms whereby guanosine 3',5'-cyclic monophosphate (cGMP) modulates microvessel permeability in vivo, we measured changes in microvessel hydraulic conductivity (L(p)) and endothelial cytoplasmic Ca2+ concentration ([Ca2+](i)) in response to the cGMP analogs 8-bromo-cGMP (8-BrcGMP) and 8-(p-chlorophenylthio)cGMP (8-pCPT-cGMP) in the presence and absence of inflammatory stimuli in intact individually perfused microvessels in frog and rat mesenteries. The cGMP analog caused a transient increase in L(p) and potentiated ATP or bradykinin-induced increases in L(p) in frog and rat mesenteric microvessels, respectively. The mean peak value of the test L(p)/control L(p) after exposure to 8-BrcGMP was 5.3 ± 0.5 in frog microvessels and 2.8 ± 0.4 in rat microvessels. The ATP- induced increase in L(p) in frog microvessels was further raised by 8-BrcGMP from 7.0 ± 0.9 to 12.4 ± 1.9 times the control. In rat mesenteric microvessels, the bradykinin-induced increase in L(p) was potentiated by 8- BrcGMP from 4.8 ± 0.4 to 8.3 ± 1.3 times the control and was suppressed by the guanylate cyclase inhibitor LY-83583 to 2.6 ± 0.5 times the control. A similar but larger effect was found when using 8-pCPT-cGMP. In contrast to the actions of increased cGMP on microvessel permeability, cGMP analogs had no effect on basal endothelial [Ca2+](i) and did not alter the magnitude and time course of ATP or bradykinin-induced increases in endothelial [Ca2+](i). These results suggested that an elevation of cGMP levels in endothelial cells is a necessary step to increase microvessel permeability in intact microvessels, and this regulatory process occurs downstream from Ca2+ influx, which differs from that reported in large-vessel endothelium in culture and in vascular smooth muscle cells. Experiments carried on microvessels in both frog and rat mesenteries provided a direct comparison of the endothelial cell regulatory mechanisms between species.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume274
Issue number6 43-6
StatePublished - 1998
Externally publishedYes

Fingerprint

Microvessels
Permeability
Anura
Bradykinin
Mesentery
Adenosine Triphosphate
6-anilino-5,8-quinolinedione
Endothelial Cells
Guanylate Cyclase
Cyclic GMP
Vascular Smooth Muscle
Smooth Muscle Myocytes
Endothelium

Keywords

  • Adenosine 5'- triphosphate
  • Bradykinin
  • Guanosine 3',5'-cyclic monophosphate analog
  • Guanylate cyclase inhibitor LY-83583
  • Hydraulic conductivity

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

cGMP modulates basal and activated microvessel permeability independently of [Ca2+](i). / He, P.; Zeng, M.; Curry, F. E.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 274, No. 6 43-6, 1998.

Research output: Contribution to journalArticle

@article{5ef58350fd494b439bad722f7949fcfb,
title = "cGMP modulates basal and activated microvessel permeability independently of [Ca2+](i)",
abstract = "To investigate the mechanisms whereby guanosine 3',5'-cyclic monophosphate (cGMP) modulates microvessel permeability in vivo, we measured changes in microvessel hydraulic conductivity (L(p)) and endothelial cytoplasmic Ca2+ concentration ([Ca2+](i)) in response to the cGMP analogs 8-bromo-cGMP (8-BrcGMP) and 8-(p-chlorophenylthio)cGMP (8-pCPT-cGMP) in the presence and absence of inflammatory stimuli in intact individually perfused microvessels in frog and rat mesenteries. The cGMP analog caused a transient increase in L(p) and potentiated ATP or bradykinin-induced increases in L(p) in frog and rat mesenteric microvessels, respectively. The mean peak value of the test L(p)/control L(p) after exposure to 8-BrcGMP was 5.3 ± 0.5 in frog microvessels and 2.8 ± 0.4 in rat microvessels. The ATP- induced increase in L(p) in frog microvessels was further raised by 8-BrcGMP from 7.0 ± 0.9 to 12.4 ± 1.9 times the control. In rat mesenteric microvessels, the bradykinin-induced increase in L(p) was potentiated by 8- BrcGMP from 4.8 ± 0.4 to 8.3 ± 1.3 times the control and was suppressed by the guanylate cyclase inhibitor LY-83583 to 2.6 ± 0.5 times the control. A similar but larger effect was found when using 8-pCPT-cGMP. In contrast to the actions of increased cGMP on microvessel permeability, cGMP analogs had no effect on basal endothelial [Ca2+](i) and did not alter the magnitude and time course of ATP or bradykinin-induced increases in endothelial [Ca2+](i). These results suggested that an elevation of cGMP levels in endothelial cells is a necessary step to increase microvessel permeability in intact microvessels, and this regulatory process occurs downstream from Ca2+ influx, which differs from that reported in large-vessel endothelium in culture and in vascular smooth muscle cells. Experiments carried on microvessels in both frog and rat mesenteries provided a direct comparison of the endothelial cell regulatory mechanisms between species.",
keywords = "Adenosine 5'- triphosphate, Bradykinin, Guanosine 3',5'-cyclic monophosphate analog, Guanylate cyclase inhibitor LY-83583, Hydraulic conductivity",
author = "P. He and M. Zeng and Curry, {F. E.}",
year = "1998",
language = "English (US)",
volume = "274",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "6 43-6",

}

TY - JOUR

T1 - cGMP modulates basal and activated microvessel permeability independently of [Ca2+](i)

AU - He, P.

AU - Zeng, M.

AU - Curry, F. E.

PY - 1998

Y1 - 1998

N2 - To investigate the mechanisms whereby guanosine 3',5'-cyclic monophosphate (cGMP) modulates microvessel permeability in vivo, we measured changes in microvessel hydraulic conductivity (L(p)) and endothelial cytoplasmic Ca2+ concentration ([Ca2+](i)) in response to the cGMP analogs 8-bromo-cGMP (8-BrcGMP) and 8-(p-chlorophenylthio)cGMP (8-pCPT-cGMP) in the presence and absence of inflammatory stimuli in intact individually perfused microvessels in frog and rat mesenteries. The cGMP analog caused a transient increase in L(p) and potentiated ATP or bradykinin-induced increases in L(p) in frog and rat mesenteric microvessels, respectively. The mean peak value of the test L(p)/control L(p) after exposure to 8-BrcGMP was 5.3 ± 0.5 in frog microvessels and 2.8 ± 0.4 in rat microvessels. The ATP- induced increase in L(p) in frog microvessels was further raised by 8-BrcGMP from 7.0 ± 0.9 to 12.4 ± 1.9 times the control. In rat mesenteric microvessels, the bradykinin-induced increase in L(p) was potentiated by 8- BrcGMP from 4.8 ± 0.4 to 8.3 ± 1.3 times the control and was suppressed by the guanylate cyclase inhibitor LY-83583 to 2.6 ± 0.5 times the control. A similar but larger effect was found when using 8-pCPT-cGMP. In contrast to the actions of increased cGMP on microvessel permeability, cGMP analogs had no effect on basal endothelial [Ca2+](i) and did not alter the magnitude and time course of ATP or bradykinin-induced increases in endothelial [Ca2+](i). These results suggested that an elevation of cGMP levels in endothelial cells is a necessary step to increase microvessel permeability in intact microvessels, and this regulatory process occurs downstream from Ca2+ influx, which differs from that reported in large-vessel endothelium in culture and in vascular smooth muscle cells. Experiments carried on microvessels in both frog and rat mesenteries provided a direct comparison of the endothelial cell regulatory mechanisms between species.

AB - To investigate the mechanisms whereby guanosine 3',5'-cyclic monophosphate (cGMP) modulates microvessel permeability in vivo, we measured changes in microvessel hydraulic conductivity (L(p)) and endothelial cytoplasmic Ca2+ concentration ([Ca2+](i)) in response to the cGMP analogs 8-bromo-cGMP (8-BrcGMP) and 8-(p-chlorophenylthio)cGMP (8-pCPT-cGMP) in the presence and absence of inflammatory stimuli in intact individually perfused microvessels in frog and rat mesenteries. The cGMP analog caused a transient increase in L(p) and potentiated ATP or bradykinin-induced increases in L(p) in frog and rat mesenteric microvessels, respectively. The mean peak value of the test L(p)/control L(p) after exposure to 8-BrcGMP was 5.3 ± 0.5 in frog microvessels and 2.8 ± 0.4 in rat microvessels. The ATP- induced increase in L(p) in frog microvessels was further raised by 8-BrcGMP from 7.0 ± 0.9 to 12.4 ± 1.9 times the control. In rat mesenteric microvessels, the bradykinin-induced increase in L(p) was potentiated by 8- BrcGMP from 4.8 ± 0.4 to 8.3 ± 1.3 times the control and was suppressed by the guanylate cyclase inhibitor LY-83583 to 2.6 ± 0.5 times the control. A similar but larger effect was found when using 8-pCPT-cGMP. In contrast to the actions of increased cGMP on microvessel permeability, cGMP analogs had no effect on basal endothelial [Ca2+](i) and did not alter the magnitude and time course of ATP or bradykinin-induced increases in endothelial [Ca2+](i). These results suggested that an elevation of cGMP levels in endothelial cells is a necessary step to increase microvessel permeability in intact microvessels, and this regulatory process occurs downstream from Ca2+ influx, which differs from that reported in large-vessel endothelium in culture and in vascular smooth muscle cells. Experiments carried on microvessels in both frog and rat mesenteries provided a direct comparison of the endothelial cell regulatory mechanisms between species.

KW - Adenosine 5'- triphosphate

KW - Bradykinin

KW - Guanosine 3',5'-cyclic monophosphate analog

KW - Guanylate cyclase inhibitor LY-83583

KW - Hydraulic conductivity

UR - http://www.scopus.com/inward/record.url?scp=0031803396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031803396&partnerID=8YFLogxK

M3 - Article

C2 - 9841514

VL - 274

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 6 43-6

ER -